Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Sales (2020 - 2025)

Biofrontera has reported Return on Sales over the past 6 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Sales for Q4 2025 was 0.0% at Biofrontera, up from 0.01% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q1 2022 and troughed at 0.04% in Q3 2021.
  • A 5-year average of 0.01% and a median of 0.01% in 2021 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: fell -3bps in 2021 and later increased 3bps in 2022.
  • Year by year, Return on Sales stood at 0.02% in 2021, then surged by 83bps to 0.0% in 2022, then soared by 221bps to 0.0% in 2023, then plummeted by -133bps to 0.0% in 2024, then soared by 397bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for BFRI at 0.0% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.